Biovie BIVI
NASDAQ BIVI
$1.21 -0.03 (-2.42%)
As of: Oct 21, 2026 · 11:35 AM EDT

Biovie (BIVI) Current Debt (2017 - 2018)

Updated

Analysis

Biovie (BIVI) Current Debt (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -5.75 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 64.00 Mn
10 Biovie 8.77 Mn -58.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -14,000.00
Sep 30, 2017 -25,000.00
API Access

Biovie Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=BIVI&period=max&api_key=YOUR_API_KEY